Clinical Trial Update: Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics [Phase 1]

View source ↗

Summary

Phase 1 study assessing how moderate renal impairment and race/ethnicity influence treosulfan pharmacokinetics in Acute Myeloid Leukemia and Myelodysplastic Syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Treosulfan (treosulfan)

Snippet

Sponsor: medac GmbH | Conditions: Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) | Phase 1 | Status: RECRUITING